Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry
Catheterization and Cardiovascular Interventions · 2023
DOI: 10.1002/ccd.30804 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2023. Verfasst von Pablo Salinas und 19 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain. Hauptthemen laut MEDLINE: Coronary Artery Disease, Percutaneous Coronary Intervention, Cardiac Catheterization, Coronary Artery Bypass. Die Arbeit nennt 22 Literaturangaben. Gefördert von: Laboratorios Rovi SA.
Abstract (Originalsprache)
Background
Myocardial revascularization failure (MRF) and Secondary revascularization (SR) are contemporary interventional cardiology challenges.
Aim
To investigate the characteristics, management, and prognosis of patients with myocardial revascularization failure (MRF) and need for secondary revascularization (SR) in contemporary practice.
Methods
The REVASEC study is a prospective registry (NCT03349385), which recruited patients with prior revascularization referred for coronary angiography at 19 centers. The primary endpoint is a patient‐oriented composite (POCE) at 1 year, including death, myocardial infarction, or repeat revascularization.
Results
A total of 869 patients previously revascularized by percutaneous intervention (83%) or surgery (17%) were recruited. MRF was found in 83.7% (41.1% stent/graft failure, 32.1% progression of coronary disease, and 10.5% residual disease). SR was performed in 70.1%, preferably by percutaneous intervention (95%). The POCE rate at 1 year was 14% in the overall cohort, with 6.4% all‐cause death. In the multivariate analysis, lower POCE rates were found in the groups without MRF (9.4%) and with disease progression (11%) compared with graft/stent failure (17%) and residual disease (18%), hazard ratio 0.67 (95% confidence interval: 0.45–0.99), p = 0.043. At 1 year, the SR group had less chronic persistent angina (19% vs. 34%, p < 0.001), but a higher rate of repeat revascularization (9% vs. 2.9%, p < 0.001).
Conclusion
MRF was found in 84% of patients with prior revascularization referred for coronary angiography. Stent/graft failure and residual coronary disease were associated with a worse prognosis. SR provided better symptom control at the expense of a higher rate of new revascularization
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
- Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
- Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
- Hospital Clínic de Barcelona, Barcelona, Spain.
- Instituto de Investigación Sanitaria INCLIVA, Hospital Clínico Universitario de Valencia, Valencia, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
ORCID-Profile: Pablo Salinas, Sergio García-Blas, Soledad Ojeda, Jean Paul Vilchez-Tschischke, Ignacio Amat-Santos, Juan Rondán
Förderung
- Laboratorios Rovi SA
Zitieren
APA
Salinas, P., García-Camarero, T., Jimenez-Kockar, M., Regueiro, A., García-Blas, S., Gomez-Menchero, A. E., Ojeda, S., Vilchez-Tschischke, J. P., Amat-Santos, I., Díez-Gil, J. L., Rondán, J., Lozano Ruiz-Poveda, F., de Miguel Castro, A., Manzano, M. C., Pascual-Tejerina, V., Cruz-González, I., García Perez-Velasco, J., Fernández-Diaz, J. A., Escaned, J., & REVASEC working group (collaborators) (2023). Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30804
Vancouver
Salinas P, García-Camarero T, Jimenez-Kockar M, Regueiro A, García-Blas S, Gomez-Menchero AE, et al. Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry. Catheterization and Cardiovascular Interventions. 2023. doi:10.1002/ccd.30804
BibTeX
@article{Salinas2023,
author = {Salinas, Pablo and García-Camarero, Tamara and Jimenez-Kockar, Marcelo and Regueiro, Ander and García-Blas, Sergio and Gomez-Menchero, Antonio E and Ojeda, Soledad and Vilchez-Tschischke, Jean Paul and Amat-Santos, Ignacio and Díez-Gil, Jose Luis and Rondán, Juan and Lozano Ruiz-Poveda, Fernando and de Miguel Castro, Antonio and Manzano, Maria C and Pascual-Tejerina, Virginia and Cruz-González, Ignacio and García Perez-Velasco, Javier and Fernández-Diaz, Jose A and Escaned, Javier and REVASEC working group (collaborators), REVASEC working group (collaborators)},
title = {Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry},
journal = {Catheterization and Cardiovascular Interventions},
year = {2023},
doi = {10.1002/ccd.30804}
}
EUVIMED